Safety and Efficacy of Autologous Bone Marrow Derived Mononuclear Cell Transplant in the Management of Various Neurological Disorders
Sanjay Kala, Anchal Aggarwal, Bhagat Singh Rajput, Chayanika Kala, Santosh K Barman · 2024
Read Safety and Efficacy of Autologous Bone Marrow Derived Mononuclear Cell Transplant in the Management of Various Neurological Disorders by Sanjay Kala, Anchal Aggarwal, Bhagat Singh Rajput, Chayanika Kala, Santosh K Barman (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11725325.txt.
Description
Sanjay Kala and co-authors test a bone marrow cell transplant across several nerve disorders in a 2024 study. Cerebral palsy, spinal cord injury, and muscular dystrophy are chronic conditions with no cure, and current care only eases symptoms. The team asked whether a patient's own bone marrow cells could improve function safely.
One hundred patients at an Indian medical college received their own processed marrow cells, given into the spinal fluid or into muscle. Function was scored with standard scales for each condition, before treatment and after later cycles, and quality of life was also tracked. The single arm, open label design has no control group, so gains are read against each patient's own baseline.
Catalog record
| CREATOR | Sanjay Kala, Anchal Aggarwal, Bhagat Singh Rajput, Chayanika Kala, Santosh K Barman |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |